In the future, Chinese patent medicines made in Macao will be recognized by more countries and regions,
The traditional Chinese medicine industry is one of the key industries to promote the moderately diversified development of Macao's economy. At the end of last year, Guangyao group, a leading enterprise with traditional Chinese medicine as its main business, built Guangyao International (Macao) pharmaceutical factory in Macao's Qingzhou cross-border industrial zone, hoping to accelerate the overseas expansion of famous and high-quality Chinese patent medicines "made in Macao" by relying on Macao's policies and geographical advantages.
At present, Guangyao International (Macao) pharmaceutical factory has been put into operation and completed for nearly two months. Li Hong, general manager of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) , told Nanfang finance and economics all media that at present, some Chinese patent medicines manufactured by Guangyao International (Macao) pharmaceutical factory have obtained the listing license in Macao and will launch a series of new products in the first quarter of 2022.
"made in Macao"
"This pharmaceutical factory is the largest and the first traditional Chinese medicine pharmaceutical factory designed and built in accordance with modern GMP standards in Macao. It is a landmark project of Guangzhou Pharmaceutical Group to help Macao's moderately diversified economic development." Li Hong introduced.
On December 17, 2021, Guangyao International (Macao) pharmaceutical factory was officially completed and put into operation. The first phase of the project covers an area of 2341.82 square meters. It is equipped with production lines of traditional Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniments. It has obtained the production license for pharmaceutical industry issued by the Macao SAR government. Phase II will gradually lay oral liquid, beverage Emulsion and other production lines, and strive to create a number of "made in Macao" high-quality traditional Chinese medicine and great health products.
Li Chuyuan, party secretary and chairman of Guangzhou Pharmaceutical Group, told reporters that he hoped to promote the standardization, industrialization and modernization of Macao's traditional Chinese medicine industry through the construction of GMP standard traditional Chinese medicine factory. On the other hand, it also gives full play to the advantages of "one country, two systems" to speed up the going out of traditional Chinese medicine enterprises represented by Guangzhou Pharmaceutical Group. Guangzhou Pharmaceutical Group is based in Guangzhou and its international headquarters is in Macao. In the way of "one enterprise and two places", it gives full play to the resource advantages of the two places, promotes "one product and two sales", faces the Chinese and international markets more, and accelerates the internationalization of traditional Chinese medicine. "Guangdong and Macao complement each other's advantages and achieve win-win results, which can make a positive exploration for building an innovation highland of traditional Chinese medicine in the Great Bay area of Guangdong, Hong Kong and Macao."
Shortly after Guangyao International (Macao) pharmaceutical factory was completed and put into operation, it was faced with an outbreak in Zhuhai, and the epidemic prevention measures in Zhuhai and Macao were tightened again. "Even in the face of the pressure of Zhuhai epidemic, we still strive to overcome the impact of the epidemic and produce Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Banlangen, Ganoderma lucidum spore oil and other famous and high-quality products of Guangzhou Pharmaceutical Group." Huang Ying, assistant general manager of Guangzhou Pharmaceutical Group (Macao) International Development Industry Co., Ltd., told reporters that at present, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Banlangen Granules 10g and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) compound Banlangen Granules 15g manufactured by Guangzhou Pharmaceutical International (Macao) pharmaceutical factory have obtained the listing license in Macao, and the international version of Lingzhi spore oil of Guangzhou Pharmaceutical brand has also been listed in Macao.
Shortly after Guangyao International (Macao) pharmaceutical factory was put into operation, Macao's law on traditional Chinese medicine activities and registration of Chinese patent medicines and Macao food and drug administration were established on January 1, 2022. Li Chuyuan believes that this is conducive to further ensuring the quality and safety of traditional Chinese medicines legally produced, imported and circulated in Macao, standardizing the registration of Chinese patent medicines and improving the export competitiveness of "made in Macao" Chinese patent medicines. "For Macao pharmaceutical manufacturers, this has further standardized the manufacturing, import and export, wholesale and retail of traditional Chinese medicine and the registration of Chinese patent medicine, and improved the standards of the whole industry with international standards, which will accelerate the standardized and high-quality development of traditional Chinese medicine in Macao. In the future, the Chinese patent medicine manufactured in Macao will be recognized by more countries and regions, with strong supervision and standards According to local conditions, Macao's high-quality traditional Chinese medicine will walk out of a high standard and grounded road suitable for itself. "
It is reported that Guangyao International (Macao) pharmaceutical factory will launch a series of new products in the first quarter of 2022. Huang Ying said, "at present, we are fully applying for the approval of other key dosage forms, including Angong Niuhuang Pill. What we can expect is that we are preparing to apply for dual natural Angong Niuhuang Pill in Macao, which will empower Angong Niuhuang Pill as a classic prescription and implement the innovative and improved high-quality traditional Chinese medicine in Macao."
Subsequently, Guangzhou Pharmaceutical International (Macao) pharmaceutical factory will continue to introduce Naoxinqing tablets, Xueshuantong capsules, modified Huoxiang Zhengqi pills, Ertian oil and other proprietary Chinese medicine products.
"Guangyao scheme"
Traditional Chinese medicine industry is an important field and driving force for deepening the cooperation and development between Guangdong and Macao. It is also one of the four industries committed to promoting in Hengqin Guangdong Macao deep cooperation zone. Zhang Yongchun, director of the administrative and Legal Affairs Department of the Macao Special Administrative Region, has revealed that in 2022, he will work with the Legal Affairs Bureau of the Executive Committee of Hengqin Guangdong Macao deep cooperation zone to promote the drafting of laws and regulations on the development of traditional Chinese medicine industry and professional qualification certification, which will further deepen the cooperation of traditional Chinese medicine between Guangdong and Macao.
It is understood that Guangzhou Pharmaceutical Group has established Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co., Ltd. in the Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park in Hengqin Guangdong Macao deep cooperation zone, which is positioned as a pharmaceutical R & D industrialization platform to expand the industrial development space of Macao International Headquarters, At present, projects such as Zhuhai Hengqin sub center of International Engineering Research Center for the modernization of traditional Chinese medicine extraction and separation process and Zhuhai Hengqin pharmaceutical supply chain of Guangzhou Pharmaceutical are being introduced successively.
In the future, Guangzhou Pharmaceutical Group will further introduce and cultivate the whole industry chain businesses such as identification and analysis of traditional Chinese medicine, production and sales of traditional Chinese medicine decoction pieces, R & D and manufacturing of Chinese patent medicine, R & D and manufacturing of great health care products, commercial circulation of medical commodities and health services with traditional Chinese medicine characteristics in Macao and Hengqin, and build a modern industrial production of traditional Chinese medicine and a scientific research incubation base for the Great Bay District of Guangdong, Hong Kong and Macao Southeast Asia and one belt, one road, along the border, provide a range of Chinese patent medicines and famous health products. In order to boost the moderately diversified development of Macao's economy, promote the internationalization of traditional Chinese medicine and build a human health community, more "Guangyao schemes" are provided.
